Developing a cell isolation and separation platform technology, seeking to assist in the future treatment of chronic diseases such as cancer and AIDS.

Cell Lane Ltd has been established to develop a cell isolation and separation platform technology, based on intellectual property from the University of Leeds. This technology seeks to assist in the future treatment of chronic diseases such as cancer and AIDS, and is intended to enable new fields of research in research activities such as stem cell research. The Company states that their proposed technology is intended to be used to rapidly separate cells whilst preserving their functionality and overall viability.

  • Product

    Life Sciences EIS
  • Sector

    Medicine
  • Status

    Open
  • HMRC

    Advanced Assurance